Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter





Why the drugs don't work: gene fault explains multiple sclerosis treatment failure

23 July 2012

By Holly Rogers

Appeared in BioNews 666

A genetic variation could explain why a previously promising class of drugs does not work as treatment for multiple sclerosis (MS), despite being used successfully in other autoimmune diseases.

The drugs, known as anti-TNFs - they inhibit the action of a chemical in the body called tumour necrosis factor (TNF) - are an established therapy for patients with inflammatory bowel disease and rheumatoid arthritis.

But a study carried out ten years ago showed that anti-TNFs can in fact worsen symptoms of MS. At the time, the reasons for this were unknown. Some experts suggested the drugs could even trigger the disease in those predisposed to the condition.

In the current study, the team from Oxford University investigated a genetic variant found in a gene already associated with a risk of developing MS.

The gene encodes TNF receptor 1 protein. Normally, this protein sits within a cell's membrane, where it senses TNF circulating outside the cell. Its activation starts a cascade that can lead to inflammation and cell death.

However, researchers found that the variant produces a shortened version of the protein, which is released outside of the cell, instead of anchoring to its membrane. It then 'mops up' TNF molecules, preventing them from signalling to cells and effectively performing the same process as anti-TNF drugs.

'Whilst [this] gene variant is linked to a modest risk of developing MS, the drug that mimics the effect of the variant has a considerably greater impact', said Professor Lars Fugger of the Nuffield Department of Clinical Neurosciences, who led the study. 'The effects of genetic variants influencing disease risk or resistance can be amplified by drugs. This has often been completely overlooked, but will be critical for using genetic findings in a medical context'.

The variant was discovered using a genome-wide association study (GWAS), published in Nature. GWAS collect data from thousands of people with a particular disease, and identify genetic variations that are more prevalent in those with the condition. Most studies of this kind discover dozens of significant variations, each increasing the chances of developing the condition by a small percentage.

Analysing the entire human genome has raised the hope that genetic abnormalities can be identified and used to refine or identify treatments for patients with certain disorders.

Professor Fugger said that the study 'shows that this is possible. It's one of the first such examples, certainly in autoimmune disease'.

Nick Rijke, director of policy and research at the MS Society, told BBC News that the study 'could help ensure that people with MS are offered the drug treatments that are most likely to work for them'.


 

SOURCES & REFERENCES
BBC News | 09 July 2012
 
Medical Xpress (press release) | 11 July 2012
 
Nature News | 09 July 2012
 
Nature | 08 July 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

07 October 2013 - by Julianna Photopoulos 
A group of international researchers has identified 48 new genetic variants that influence the risk of developing multiple sclerosis. This brings the number of genetic 'risk factors' linked to the disease to 110... [Read More]
24 September 2012 - by Chris Baldacci 
Scientists have discovered a gene called FGF1 which is highly active in aggressive and advanced ovarian cancers... [Read More]
13 August 2012 - by Cait McDonagh 
A faulty gene linked to bowel cancer interacts with dietary iron to significantly increase the risk of developing the disease, research on mice suggests... [Read More]
13 August 2012 - by Dr Caroline Hirst 
Chemotherapy can produce a rogue response that eventually leads to tumours becoming resistant to treatment, scientists have found... [Read More]

12 December 2011 - by Owen Clark 
A rare genetic variant causing lower levels of vitamin D has been linked to multiple sclerosis (MS), according to scientists... [Read More]
15 August 2011 - by Dr Rebecca Hill 
Researchers have identified 29 new genetic variants with a link to multiple sclerosis (MS). This brings the total number of genetic changes associated with the disease, which affects around 2.5 million people worldwide, to nearly 50... [Read More]
06 June 2011 - by Mehmet Fidanboylu 
Researchers have found a link between genetics and the environment that may help to explain the development of multiple sclerosis (MS). The study, published in Nature Communications, identified how vitamin D obtained through diet or sunlight, interacts with certain genes... [Read More]
13 December 2010 - by Chris Chatterton 
Preliminary findings from a new research study have helped give scientists a new insight into how the body naturally repairs myelin, the substance that insulates nerve cells in the brain... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation